drugset / Trial / NCT02519387
Efficacy and Safety of Buprenorphine Transdermal Patch in Non-cancer Pain of Moderate Intensity
NaSingle-groupOpen-labelTreatment
Summary
This is a phase IV, open-label and single-arm study of patients with non-malignant pain due to osteoarthritis, rheumatoid arthritis, low back pain and joint/muscle pain, who were not responding to non-opioid analgesics. The primary objective was to assess the efficacy of buprenorphine transdermal patch for pain control among these patients.
Timeline
- Start
- 2013-07
- Primary completion
- 2015-01
- Completion
- 2015-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Buprenorphine | Other / unclassified | 5 mg | Other |
| Subject | Buprenorphine | Other / unclassified | 10 mg | Other |
| Subject | Buprenorphine | Other / unclassified | 20 mg | Other |